Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Symptom control with the syringe driver 

Symptom control with the syringe driver
Chapter:
Symptom control with the syringe driver
Author(s):

Andrew Dickman

and Jennifer Schneider

DOI:
10.1093/med/9780198733720.003.0004
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 03 July 2022

Symptoms tend to increase during the last days and weeks of life and pharmacological interventions are essential for adequate alleviation. Common symptoms experienced by patients at the end of life include pain, respiratory tract secretions, agitation, delirium, restlessness, nausea, and vomiting. The oral route should be used where possible, but as the patient’s condition deteriorates, it may no longer be feasible to administer medication this way. It is likely that patients will require a combination of drugs to control their coexisting medical conditions as well as for pain and other symptom management. A CSCI provides a simple and effective way to maintain control of commonly encountered symptoms experienced by patients with advanced disease. This chapter discusses how CSCIs of certain drugs can be used to manage such symptoms.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.